Jane Street’s Dermata Therapeutics DRMA Stock Holding History

Jane Street’s Portfolio DRMA Stock Details DRMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10	Closed	-$12K	–	9319
2022 Q3	$12K	Buy	+10	New	+$15.6K	﹤0.01%	9310

Other funds holding DRMA

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

SCA

Sage Capital Advisors Sioux Falls, South Dakota $482M AUM 34.73% 1-Year Est. Return

HC Advisors Sandy Springs, Georgia $165M AUM 20.85% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Jane Street's DRMA Position: Q4 2022 in Review

Jane Street sold out of Dermata Therapeutics (DRMA) in Q4 2022, closing a stake of 10 shares — an estimated $12K sold.

Jane Street first reported a position in DRMA in Q3 2022 and held it in 1 quarter. The position peaked at $12K in Q3 2022. 10 funds tracked by Wall St. Rank hold DRMA as of Q4 2022.

Jane Street reported no remaining Dermata Therapeutics position as of Q4 2022 after selling out during the quarter.
Jane Street sold 10 Dermata Therapeutics shares in Q4 2022, an estimated $12K.
Jane Street first reported a position in Dermata Therapeutics in Q3 2022 and held it in 1 quarter.
Jane Street's Dermata Therapeutics position peaked at $12K in Q3 2022.
10 funds tracked by Wall St. Rank held Dermata Therapeutics as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.